
JAMA Psychiatry
@jamapsych
JAMA Psychiatry is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.
ID: 54953661
http://ja.ma/tjamapsychiatry 08-07-2009 16:54:06
12,12K Tweet
55,55K Followers
284 Following






Most viewed this week from JAMA Psychiatry: GLP1-RA treatment for obesity and diabetes does not increase psychiatric adverse events compared to placebo and is linked to improvements in quality of life, emotional eating, and mental well-being. ja.ma/44SshRo




Most viewed this week from JAMA Psychiatry: GLP1-RA treatment for obesity and diabetes does not increase psychiatric adverse events compared to placebo and is linked to improvements in quality of life, emotional eating, and mental well-being. ja.ma/3ZrUPNJ




Most viewed this week from JAMA Psychiatry: GLP1-RA treatment for obesity and diabetes does not increase psychiatric adverse events compared to placebo and is linked to improvements in quality of life, emotional eating, and mental well-being. ja.ma/43owISN


Most viewed this week from JAMA Psychiatry: GLP1-RA treatment for obesity and diabetes does not increase psychiatric adverse events compared to placebo and is linked to improvements in quality of life, emotional eating, and mental well-being. ja.ma/44Voqmu




Most viewed this week from JAMA Psychiatry: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. ja.ma/43S79sg



